Inflammatory Bowel Diseases

Cover image for Inflammatory Bowel Diseases

Summer 1997

Volume 3, Issue 2

Pages fmi–fmi, 65–179

  1. Masthead

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Editorial
    8. Summary
    9. Abstracts
    10. Controversies In IBD
    11. Section Editors' Commentary
    12. Selected Summaries
    1. Masthead (page fmi)

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030201

  2. Original Contributions

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Editorial
    8. Summary
    9. Abstracts
    10. Controversies In IBD
    11. Section Editors' Commentary
    12. Selected Summaries
    1. Alternatives to sulfasalazine: A meta-analysis of 5-ASA in the treatment of ulcerative colitis (pages 65–78)

      Dr. Lloyd R. Sutherland, Daniel E. Roth and Paul L. Beck

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030202

    2. Esophageal Crohn's disease: Medical management and correlation between clinical, endoscopic, and histologic features (pages 79–83)

      Dr. Toba Weinstein, Elsa Valderrama, Michael Pettei and Jeremiah Levine

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030203

  3. Clinical Trials and Therapeutics

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Editorial
    8. Summary
    9. Abstracts
    10. Controversies In IBD
    11. Section Editors' Commentary
    12. Selected Summaries
    1. IBD: A vascular disorder? the case for heparin therapy (pages 87–94)

      Dr. Joshua R. Korzenik

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030205

  4. Clinical Reviews

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Editorial
    8. Summary
    9. Abstracts
    10. Controversies In IBD
    11. Section Editors' Commentary
    12. Selected Summaries
    1. Biologic therapy for inflammatory bowel disease (pages 95–113)

      Dr. Bruce E. Sands

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030206

  5. Basic Science Reviews

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Editorial
    8. Summary
    9. Abstracts
    10. Controversies In IBD
    11. Section Editors' Commentary
    12. Selected Summaries
    1. Mechanisms and treatment of diarrhea in inflammatory bowel diseases (pages 114–131)

      Shiro Urayama and Dr. Eugene B. Chang

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030207

  6. Editorial

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Editorial
    8. Summary
    9. Abstracts
    10. Controversies In IBD
    11. Section Editors' Commentary
    12. Selected Summaries
    1. “Immune/non-immune cell interactions in intestinal inflammation” workshop (page 132)

      Richard P. MacDermott and Robert Burakoff

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030208

  7. Summary

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Editorial
    8. Summary
    9. Abstracts
    10. Controversies In IBD
    11. Section Editors' Commentary
    12. Selected Summaries
    1. “Immune/non-immune cell interactions in intestinal inflammation” workshop (pages 133–141)

      Dr. C. Fiocchi, S. M. Collins, S. P. James, L. Mayer, D. K. Podolsky and W. F. Stenson

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030209

  8. Abstracts

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Editorial
    8. Summary
    9. Abstracts
    10. Controversies In IBD
    11. Section Editors' Commentary
    12. Selected Summaries
  9. Controversies In IBD

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Editorial
    8. Summary
    9. Abstracts
    10. Controversies In IBD
    11. Section Editors' Commentary
    12. Selected Summaries
  10. Section Editors' Commentary

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Editorial
    8. Summary
    9. Abstracts
    10. Controversies In IBD
    11. Section Editors' Commentary
    12. Selected Summaries
    1. Is the prolonged use of low-dose steroids safe for Crohn's disease? (pages 174–175)

      Peter A. Banks and Daniel H. Present

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030213

  11. Selected Summaries

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Clinical Trials and Therapeutics
    5. Clinical Reviews
    6. Basic Science Reviews
    7. Editorial
    8. Summary
    9. Abstracts
    10. Controversies In IBD
    11. Section Editors' Commentary
    12. Selected Summaries
    1. Is there hope for Crohn's disease patients with anorectal/vaginal fistulas? (page 176)

      Harold L. Greenberg

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030214

    2. Crohn's disease to lump or to split? (page 177)

      David B. Sachar

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030215

    3. Cell death and clostridium difficile toxins: The murder weaponuncovered (pages 177–178)

      Ciarán P. Kelly

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030216

    4. Methotrexate for ulcerative colitis—discouraging news (pages 178–179)

      Brian G. Feagan

      Version of Record online: 14 DEC 2006 | DOI: 10.1002/ibd.3780030217

SEARCH

SEARCH BY CITATION